Recruiting NA INTERVENTIONAL 2-arm NCT07139301

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation (TIMERS-1)

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation：a Randomised Controlled Trial

Sponsor: Capital Medical University

Conditions Atrial Fibrillation Ischemic Stroke

Interventions Delayed anticoagulation Early anticoagulation

Updated 3 times since 2025 Last updated: Feb 4, 2026 Started: Sep 4, 2025 Primary completion: Aug 31, 2026 Completion: Aug 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Atrial Fibrillation and Ischemic Stroke and is currently actively recruiting participants. Capital Medical University leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

3 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA
Oct 2025 — Feb 2026 [monthly]

Recruiting NA
Sep 2025 — Oct 2025 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capital Medical University

Data source: Capital Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baoding, China , Baotou, China , Beijing, China , Feicheng, China , Guoluo, China , Harbin, China , Heyuan, China , Huanghua, China , Jiamusi, China , Jiaozuo, China and 26 more locations